Results 231 to 240 of about 854,739 (262)
Some of the next articles are maybe not open access.
Immunotherapies in Diabetes Mellitus Type 1
Medical Clinics of North America, 2012Type 1 diabetes is an autoimmune disease that gradually destructs insulin-producing beta cells. Over the years, clinicians' knowledge regarding the immunopathogenesis of this disease has greatly increased. Immunotherapies that can change the course of immune-mediated destruction and preserve and possibly regenerate the pancreatic beta cells seem to be ...
openaire +2 more sources
Prevention of Type 1 Diabetes Mellitus
2009Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing beta cells in the pancreas. Genetic, metabolic, and environmental factors act together to precipitate the onset of the disease. The excess mortality associated with complications of T1D and the increasing incidence of childhood T1D emphasize the importance of therapeutic
Paolo Pozzilli, Chiara Guglielmi
openaire +2 more sources
Autoantigens in type 1 diabetes mellitus
Journal of Endocrinological Investigation, 1994Dotta F +3 more
openaire +5 more sources
COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Nature Reviews Endocrinology, 2021Hyuk-sang Kwon +2 more
exaly
Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
Journal of Diabetes Investigation, 2010Eiichi Araki +2 more
exaly
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Nature Reviews Endocrinology, 2018Yan Zheng, Sylvia H Ley, Frank B Hu
exaly